| 产品描述: | Aurora kinase inhibitor-2 is a selective and ATP-competitive Aurora kinase inhibitor with IC50s of 310 nM and 240 nM for Aurora A and Aurora B, respectively |
| 靶点: |
Aurora A:310 nM (IC50);Aurora B:240 nM (IC50) |
| 参考文献: |
1. Andrew A Mortlock, et al. Progress in the development of selective inhibitors of aurora kinases. Curr Top Med Chem. 2005;5(8):807-21.2. Nicola M Heron, et al. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1320-3. |
| 溶解性: |
DMSO : 100 mg/mL (249.73 mM; Need ultrasonic) |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.497 ml |
12.487 ml |
24.973 ml |
| 5 mM |
0.499 ml |
2.497 ml |
4.995 ml |
| 10 mM |
0.25 ml |
1.249 ml |
2.497 ml |
| 50 mM |
0.05 ml |
0.25 ml |
0.499 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |